How much funding has Elysium raised?

Elysium has raised $66.2M in total funding, most recently a Series C round.

Who are Elysium's investors?

Elysium's investors include General Catalyst, Morningside Group, Breyer Capital, Mayo Clinic.

Where is Elysium headquartered?

Elysium is headquartered in New York, New York, United States.

What industry is Elysium in?

Elysium operates in Life Sciences, Healthcare.

Elysium

Start your longevity routine

New York, United States · Founded 2014 · $66.2M raised

Life Sciences

Healthcare

Headquarters: New York, New York
Employees: 11–50
Founded: 2014
Business Model: B2C

Website: elysiumhealth.com
Total Funding: $66.2M
Last Round: $40.0M Series CDec 2019
Rounds: 3

About

Elysium Health is a longevity science company founded in 2014 and headquartered in New York. The company translates critical scientific advancements in aging research into accessible health products and technologies, working with over 25 world-renowned scientists and clinicians. Its flagship product, Basis, is a clinically studied NAD+ supplement designed to support cellular energy, healthy DNA maintenance, and the aging process. Elysium also offers a biological age test called Index, alongside additional supplements targeting metabolic aging, collagen, brain health, and immune support. The company has conducted 16+ completed and ongoing human clinical trials and maintains research collaborations with Oxford and Yale.

Summary

Elysium is a Life Sciences company based in New York, United States, founded in 2014. It has raised $66.2M in total across 3 rounds, most recently a $40.0M Series C round in Dec 2019. Investors include General Catalyst, Morningside Group and Breyer Capital.

LinkedIn X (Twitter)